Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
D000588:Amines / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001921:Brain / Q000166:cytology; D006207:Half-Life; D006834:Hydrazines / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D008928:Mitochondria / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D008995:Monoamine Oxidase / Q000096:biosynthesis / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000201:enzymology; D009526:Nialamide / Q000494:pharmacology; D009929:Organ Size; D010080:Oxazoles / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D013363:Submandibular Gland / Q000166:cytology / Q000201:enzymology; D014191:Tranylcypromine / Q000494:pharmacology
D000588:Amines; D001565:Benzoates; D001593:Benzyl Compounds; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D014191:Tranylcypromine; D010293:Pargyline; D008995:Monoamine Oxidase; D007545:Isoproterenol; D009526:Nialamide